Who Benefits From Immunotherapy?
Success of immune checkpoint inhibitors in clinical trials does not always carry over to patients in the clinic.
Progress Against Cancer
Success of immune checkpoint inhibitors in clinical trials does not always carry over to patients in the clinic.
Is it the beginning of the end or the end of the beginning?
Many cancer patients have problems with memory or thinking that can linger for years after treatment. The cause is...
FDA approves neoadjuvant immunotherapy treatment for lung cancer, and radiation might not be needed for low-risk thyroid cancer.
This year, the American Association for Cancer Research (AACR) will celebrate its 115th birthday. From the very beginning, women...
Study finds lower rates of screening-related breast cancer overdiagnosis and other cancer research news of the week.
Screening program reduces disparities in colorectal cancer, and seeing the challenges of getting cancer care through one woman’s story.
Guest post by Patrick Williams, PhDAACR Scientific Research Analyst In a virtual Congressional briefing on February 9, 2022, the...
Aspirin is ineffective in preventing breast cancer recurrence, and immunotherapy holds promise for some patients with advanced anal cancer.
Millions miss cancer screenings, and commercial tobacco ban goes into effect for Navajo Nation after years of failed attempts.